ArticleThe Journal of clinical investigation2019

ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration.

Takuo Hirose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.